![[(3S,5S)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydrox...](https://static.cymitquimica.com/cas-image/21091-3s-5s-7-2-4-fluorophenyl-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl-35-dihydroxy-heptanoyl-oxysodium.png)
CAS 501121-34-2: [(3S,5S)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoyl]oxysodium
Fórmula:C33H34FN2NaO5
InChI:InChI=1/C33H35FN2O5.Na/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40;/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40);/q;+1/p-1/t26-,27-;/m0./s1
- Sinónimos:
- S,S-Atorvastatin
Ref: 41-Y0002310
| 0.03mg | 115,00 € |
Entrega estimada en Estados Unidos, el Martes 25 de Marzo de 2025
Atorvastatin EP Impurity E (Atorvastatin USP Related Compound E (Free Form), ent-Atorvastatin)
CAS:501121-34-2
Fórmula:
C33H35FN2O5
Peso molecular:
558.65
Ref: 4Z-A-1220
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 20mg | 2.206,00 € | ||
| 25mg | A consultar | ||
| 30mg | 2.846,00 € | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 28 de Marzo de 2025
(3S,5S)-Atorvastatin
CAS:501121-34-2
ent-Atorvastatin is a selective and competitive inhibitor of HMGCR (HMG-CoA reductase).
Fórmula:
C33H35FN2O5
Forma y color:
Solid
Peso molecular:
558.65
Ref: TM-T21080
| 2mg | 110,00 € | ||
| 5mg | 187,00 € | ||
| 1mL*10mM (DMSO) | 230,00 € |
Entrega estimada en Estados Unidos, el Martes 1 de Abril de 2025
(3S,5S)-Atorvastatin sodium salt
CAS:501121-34-2
Please enquire for more information about (3S,5S)-Atorvastatin sodium salt including the price, delivery time and …
Fórmula:
C33H34FN2NaO5
Pureza:
Min. 95%
Forma y color:
Powder
Peso molecular:
580.62 g/mol
Ref: 3D-IA18023
| 2mg | 199,00 € | ||
| 5mg | 318,00 € | ||
| 10mg | 448,00 € | ||
| 25mg | 664,00 € | ||
| 50mg | 886,00 € |
Entrega estimada en Estados Unidos, el Lunes 7 de Abril de 2025
